Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jongwhan Park
Fibroblast Growth Factor-2 (FGF2) and Syndecan-1 (SDC1) Are Potential Biomarkers for Putative Circulating CD15+/CD30+ Cells in Poor Outcome Hodgkin Lymphoma Patients
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Related publications
HoxA10 Protein Regulates Transcription of Gene Encoding Fibroblast Growth Factor 2 (FGF2) in Myeloid Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Fibroblast Growth Factor 2 (FGF2) Is Necessary for the Antidepressant Effects of Fluoxetine in Chronically Stressed Mice
Cd30-Chimeric Antigen Receptor (Car) T Cells for Therapy of Hodgkin Lymphoma (Hl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Syndecan-1 Expression Inhibits Myoblast Differentiation Through a Basic Fibroblast Growth Factor-Dependent Mechanism
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Therapeutic Potential of Fibroblast Growth Factor-2 for Hypertrophic Scars: Upregulation of MMP-1 and HGF Expression
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Heparan Sulphate Glycosaminoglycans Derived From Endothelial Cells and Smooth Muscle Cells Differentially Modulate Fibroblast Growth Factor-2 Biological Activity Through Fibroblast Growth Factor Receptor-1
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Transforming Growth Factor Beta 1 Regulates Fibroblast Growth Factor 7 Expression in Schwann Cells
Ochsner Journal
Medicine
Circulating Levels of TNF Receptor II Are Prognostic for Patients With Peripheral T-Cell Non-Hodgkin Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
